(NOBL) ProShares SP500 Dividend - Ratings and Ratios
Equity, Dividend, Index, ETF
Dividends
| Dividend Yield | 2.09% |
| Yield on Cost 5y | 3.04% |
| Yield CAGR 5y | 4.58% |
| Payout Consistency | 98.1% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 10.3% |
| Value at Risk 5%th | 17.3% |
| Relative Tail Risk | 1.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -2.89 |
| CAGR/Max DD | 0.47 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.240 |
| Beta | 0.554 |
| Beta Downside | 0.524 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.36% |
| Mean DD | 3.57% |
| Median DD | 3.04% |
Description: NOBL ProShares SP500 Dividend January 02, 2026
The ProShares S&P 500 Dividend Aristocrats ETF (ticker NOBL) seeks to replicate the performance of the S&P 500 Dividend Aristocrats Index, which includes S&P 500 constituents that have raised their cash dividends for at least 25 consecutive years. The fund typically invests at least 80 % of assets in the index’s constituents or securities with comparable economic characteristics.
Key metrics (as of Q4 2025): expense ratio 0.35 %, dividend yield ≈ 2.0 % annualized, total assets under management ≈ $11 billion, and a 5-year annualized total return of roughly 9 %. The ETF’s top holdings are dominated by large-cap dividend-paying firms such as Johnson & Johnson, Procter & Gamble, and Coca-Cola.
Sector allocation is heavily weighted toward Consumer Staples (≈ 30 %), Health Care (≈ 25 %), and Industrials (≈ 20 %). These sectors tend to be less cyclical, which historically buffers the fund during periods of rising interest rates-a primary macro driver of dividend-focused equity performance. Additionally, the fund’s exposure to companies with entrenched dividend policies provides a modest defensive tilt in volatile markets.
For a deeper quantitative dive into NOBL’s risk-adjusted performance and how it fits into a value-oriented portfolio, you might explore the analytics on ValueRay.
What is the price of NOBL shares?
Over the past week, the price has changed by +1.32%, over one month by +3.57%, over three months by +3.43% and over the past year by +10.00%.
Is NOBL a buy, sell or hold?
What are the forecasts/targets for the NOBL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 115.5 | 8.7% |
NOBL Fundamental Data Overview January 03, 2026
Beta = 0.77
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 11.22b USD (11.22b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 11.22b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 11.22b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.06% (E(11.22b)/V(11.22b) * Re(8.06%) + (debt-free company))
Discount Rate = 8.06% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for NOBL ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle